Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients w...

por Rothlin, Rodolfo Pedro, Pelorosso, Facundo Germán, Duarte, Mariano, Nicolosi, Liliana, Ignacio, Fernandez Criado, Salgado, María Victoria, Vetulli, Héctor
Publicado 2023

Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials

por Rothlin, Rodolfo Pedro, Duarte, Mariano, Pelorosso, Facundo Germán, Nicolosi, Liliana, Salgado, M. Victoria, Vetulli, Héctor Miguel, Spitzer, Eduardo
Publicado 2021

Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial

por Duarte, Mariano, Pelorosso, Facundo, Nicolosi, Liliana N., Victoria Salgado, M., Vetulli, Héctor, Aquieri, Analía, Azzato, Francisco, Castro, Marcela, Coyle, Javier, Davolos, Ignacio, Criado, Ignacio Fernandez, Gregori, Rosana, Mastrodonato, Pedro, Rubio, María C., Sarquis, Sergio, Wahlmann, Fernando, Rothlin, Rodolfo P.
Publicado 2021

Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial

por Cohen, Jordana B, Hanff, Thomas C, William, Preethi, Sweitzer, Nancy, Rosado-Santander, Nelson R, Medina, Carola, Rodriguez-Mori, Juan E, Renna, Nicolás, Chang, Tara I, Corrales-Medina, Vicente, Andrade-Villanueva, Jaime F, Barbagelata, Alejandro, Cristodulo-Cortez, Roberto, Díaz-Cucho, Omar A, Spaak, Jonas, Alfonso, Carlos E, Valdivia-Vega, Renzo, Villavicencio-Carranza, Mirko, Ayala-García, Ricardo J, Castro-Callirgos, Carlos A, González-Hernández, Luz A, Bernales-Salas, Eduardo F, Coacalla-Guerra, Johanna C, Salinas-Herrera, Cynthia D, Nicolosi, Liliana, Basconcel, Mauro, Byrd, James B, Sharkoski, Tiffany, Bendezú-Huasasquiche, Luis E, Chittams, Jesse, Edmonston, Daniel L, Vasquez, Charles R, Chirinos, Julio A
Publicado 2021